An improved understanding of genomics is changing how patients with thyroid cancer are treated from small incidentally diagnosed thyroid cancers to advanced anaplastic thyroid cancers. In this talk the application of genomics will be explored for thyroid cancer and how these approaches will continue to change management in the future.